The launch of Atrium Therapeutics marks a pivotal shift in the landscape of cardiovascular medicine, emerging as a specialized spin-off following Novartis’s multi-billion dollar acquisition of Avidity. Led by Kathleen Gallagher, the former Chief Program Officer of Avidity, the company is tasked w
The intersection of digital healthcare innovation and judicial oversight has reached a critical juncture that could redefine how millions of Americans access essential reproductive medications. As the landscape of reproductive healthcare continues to shift, medication abortion has emerged as the
Alaska finds itself navigating a perplexing financial reality where the cost of maintaining its correctional infrastructure has climbed to unprecedented heights despite the number of incarcerated individuals remaining remarkably consistent over several years. For the first time in the history of
The seamless flow of medical records across the United States has hit a massive legal roadblock that threatens to upend the delicate balance between patient privacy and digital accessibility. At the center of this high-stakes confrontation is a lawsuit filed by Epic Systems against Health Gorilla,
The landscape of oncology has fundamentally shifted from a reliance on broad-spectrum toxicities toward the surgical precision of molecularly targeted interventions that exploit specific genetic vulnerabilities within tumor cells. This transition defines the current struggle against metastatic
The federal government is fundamentally reshaping its approach to protecting taxpayer dollars by dismantling the traditional reactive mechanisms of the past while prioritizing immediate prevention. For decades, Medicare and Medicaid operated under a pay-and-chase philosophy that allowed billions to
